in Newswire Published on December 6, 2017

Teva Accused of Misleading Investors About Acquisition’s Success

by Erin Shaak

Last Updated on May 8, 2018

Baker v. Teva Pharmaceutical Industries Ltd. et al.

Filed: August 30, 2017 § 2:17-cv-03902-GAM

Teva Pharmaceutical Industries Ltd. and three executives have been named as defendants in a proposed class action lawsuit that accuses them of violating federal securities laws by publishing false statements regarding their financial projections.

Categories

Securities

Case Spotlight

Hair Relaxer Lawsuits

How Do I Join a Class Action Lawsuit?

ClassAction.org Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on May 8, 2018 — 6:47 PM

Erin Shaak

erin@classaction.org

Erin works primarily on ClassAction.org’s newswire, reporting on cases as they happen.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.